Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,710 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

NCT05626387

Conditions
Alveolitis, Extrinsic Allergic, Hypersensitivity, Hypersensitivity Pneumonitis, +6 more
Locations
  • Postgraduate Institute of Medical Education and Research Chandigarh, India
  • Yashoda Hospitals Hyderabad Hyderabad, India
  • Rajasthan Hospital Jaipur Jaipur, India
  • AIIMS, Jodhpur Jodhpur, India
View Trial Details
Active, Not Recruiting

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

NCT06042478

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Rosario, Santa Fe Province, Argentina
  • Novartis Investigative Site Bahía Blanca, Argentina
  • Novartis Investigative Site CABA, Argentina
View all 111 locations
View Trial Details
Active, Not Recruiting

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

NCT02612454

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Bakersfield, California, United States
  • Regeneron Investigational Site Long Beach, California, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT07205081

Conditions
Atopic Dermatitis (AD), Atopic Eczema, Atopic Eczema/Dermatitis (Non-Specific), +16 more
Locations
  • Attovia Clinical Site 203 Encinitas, California, United States
  • Attovia Clinical Site 202 Saint Joseph, Missouri, United States
  • Attovia Clinical Site 102 Peterborough, Ontario, Canada
  • Altasciences Montreal, Quebec, Canada
View Trial Details

Related conditions